Carrot Medical – Positioned for a Third Straight Record Year in 2017

Carrot Medical is pleased to report strong Year-to-Date (YTD) numbers. Key financial metrics (Revenue, EBITDA and Net Income) were all favorable once again. Comparing YTD, 2017 to YTD, 2016, total revenue increased by 3%, EBITDA more than doubled, and Net Income grew by 144%. For the first 9 months of 2017, Gross Margin improved by 9 percentage points compared to the same period in the previous year, and the cash position strengthened significantly. “Even though we’ve seen some sluggishness on the capital purchase side this year in general, Carrot’s Support, Extended Warranty and Professional Services business segments have taken up the slack nicely,” said Jeremy Wiggins, Carrot Medical CEO. “We’re early into Q4 — but we’ve already been contacted by several customers wanting to move forward now with their C-View, C-Suite and/or C-Com capital purchases so we’re encouraged about a very strong Q4 this year. This early momentum in the last quarter should position Carrot for another record year in terms of growth in Top Line Revenue, EBITDA, and Profitability.”